ORZEYFUL (oveporexton) is a first-in-class medication to treat narcolepsy type 1
As the exclusive specialty pharmacy for ORZEYFUL, Accredo® Specialty Pharmacy supports providers and patients throughout the specialty therapy journey, from referral and onboarding through ongoing treatment support.
A new approach to treating narcolepsy type 1
The U.S. Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA) approved ORZEYFUL for the treatment of narcolepsy type 1, also known as narcolepsy with cataplexy, in adults.
Support throughout the therapy journey
Simplified access and coordination
Accredo provides coordinated support to reduce delays and administrative complexity, helping your practice navigate specialty pharmacy requirements and keep patients moving toward therapy.
Visibility that keeps your practice informed
Stay connected to your patients' specialty therapy journey with timely information and support from Accredo.
Ongoing support for your patients
Patients receive education, outreach, and personalized support to help them navigate questions and challenges throughout treatment.
Ready to refer a patient to Accredo?
Access provider resources, learn ways to submit your ORZEYFUL referral or manage your patients on the My Accredo Patients portal.